Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation
- 3 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Biology Reports
- Vol. 40 (5), 3799-3805
- https://doi.org/10.1007/s11033-012-2458-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladderUrologic Oncology, 2013
- Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysisMedical Oncology, 2012
- Targeting ErbB Receptors in High-Grade GliomaCurrent Pharmaceutical Design, 2011
- Targeting ErbB3: the New RTK(id) on the Prostate Cancer BlockImmunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry, 2011
- Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancerNucleic Acids Research, 2010
- The Role of ErbB3 and its Binding Partners in Breast Cancer Progression and Resistance to Hormone and Tyrosine Kinase Directed TherapiesJournal of Mammary Gland Biology and Neoplasia, 2008
- Ebp1 Association with Nucleophosmin/B23 Is Essential for Regulating Cell Proliferation and Suppressing ApoptosisOnline Journal of Public Health Informatics, 2007
- Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation.International Journal of Oncology, 2007
- Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transferInternational Journal of Cancer, 2007
- Ectopic expression of the ErbB-3 binding protein Ebp1 inhibits growth and induces differentiation of human breast cancer cell linesJournal of Cellular Physiology, 2000